Katayoun Welin-Berger
Chief Tech/Sci/R&D Officer en EGETIS THERAPEUTICS AB .
Fortuna: 116 660 $ al 31/03/2024
Perfil
Dr. Katayoun Welin-Berger is a Vice President-Technical Operations at Egetis Therapeutics AB.
Dr. Welin-Berger was previously employed as a Vice President-Operations by Calliditas Therapeutics AB and a Vice President-Operations by BioGaia AB.
She received her doctorate degree from the University of Uppsala.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/12/2022 | 11 000 ( 0.02% ) | 116 660 $ | 31/03/2024 |
Cargos activos de Katayoun Welin-Berger
| Empresas | Cargo | Inicio |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | 01/03/2023 |
Antiguos cargos conocidos de Katayoun Welin-Berger.
| Empresas | Cargo | Fin |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Chief Operating Officer | 01/03/2023 |
| BIOGAIA AB | Compliance Officer | - |
Formación de Katayoun Welin-Berger.
| University of Uppsala | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BIOGAIA AB | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
- Bolsa de valores
- Insiders
- Katayoun Welin-Berger
